TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive In Brief: One More Committee Review Needed for L.A., Rhode Island; Animal Tests In Factories (?) May 13, 1977
TCL Archive Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release April 26, 1985
TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010